Literature DB >> 17379451

Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy.

Rahul Chopra1, Douglas Kondziolka, Ajay Niranjan, L Dade Lunsford, John C Flickinger.   

Abstract

PURPOSE: To define long-term tumor control and clinical outcomes of radiosurgery with marginal tumor doses of 12 to 13 Gy for unilateral acoustic schwannoma. METHODS AND MATERIALS: A total of 216 patients with previously untreated unilateral acoustic schwannoma underwent Gamma Knife radiosurgery between 1992 and 2000 with marginal tumor doses of 12 to 13 Gy (median, 13 Gy). Median follow-up was 5.7 years (maximum, 12 years; 41 patients with >8 years). Treatment volumes were 0.08-37.5 cm(3) (median, 1.3 cm(3)).
RESULTS: The 10-year actuarial resection-free control rate was 98.3% +/- 1.0%. Three patients required tumor resection: 2 for tumor growth and 1 partial resection for an enlarging adjacent subarachnoid cyst. Among 121 hearing patients with >3 years of follow-up, crude hearing preservation rates were 71% for keeping the same Gardner-Robertson hearing level, 74% for serviceable hearing, and 95% for any testable hearing. For 25 of these patients with intracanalicular tumors, the respective rates for preserving the same Gardner-Robertson level, serviceable hearing, and testable hearing were 80%, 88%, and 96%. Ten-year actuarial rates for preserving the same Gardner-Robertson hearing levels, serviceable hearing, any testable hearing, and unchanged facial and trigeminal nerve function were 44.0% +/- 11.7%, 44.5% +/- 10.5%, 85.3% +/- 6.2%, 100%, and 94.9% +/- 1.8%, respectively.
CONCLUSIONS: Acoustic schwannoma radiosurgery with 12 to 13 Gy provides high rates of long-term tumor control and cranial nerve preservation after long-term follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 17379451     DOI: 10.1016/j.ijrobp.2007.01.001

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  46 in total

1.  Imaging Advances in Stereotactic Radiosurgery.

Authors:  Christina Tsien; Robert E Drzymala; Keith Rich
Journal:  Mo Med       Date:  2015 Sep-Oct

Review 2.  Stereotactic radiosurgery of benign intracranial tumors.

Authors:  Bruce E Pollock
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

3.  Long-term hearing preservation after microsurgical excision of vestibular schwannoma.

Authors:  Erika Ann Woodson; Ryan Douglas Dempewolf; Samuel Paul Gubbels; Aaron Thomas Porter; Jacob Jay Oleson; Marlan Rex Hansen; Bruce Jay Gantz
Journal:  Otol Neurotol       Date:  2010-09       Impact factor: 2.311

4.  Stereotactic radiotherapy of vestibular schwannoma : Hearing preservation, vestibular function, and local control following primary and salvage radiotherapy.

Authors:  Florian Putz; Jan Müller; Caterina Wimmer; Nicole Goerig; Stefan Knippen; Heinrich Iro; Philipp Grundtner; Ilker Eyüpoglu; Karl Rössler; Sabine Semrau; Rainer Fietkau; Sebastian Lettmaier
Journal:  Strahlenther Onkol       Date:  2016-12-07       Impact factor: 3.621

5.  Hypofractionated stereotactic radiotherapy of acoustic neuroma: volume changes and hearing results after 89-month median follow-up.

Authors:  Manfred Kranzinger; Franz Zehentmayr; Gerd Fastner; Gerhard Oberascher; Florian Merz; Olaf Nairz; Hassan Rahim; Felix Sedlmayer
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

Review 6.  The emerging role of hearing loss rehabilitation in patients with vestibular schwannoma treated with Gamma Knife radiosurgery: literature review.

Authors:  Carlotta Morselli; N Boari; M Artico; M Bailo; L O Piccioni; I Giallini; M de Vincentiis; P Mortini; P Mancini
Journal:  Neurosurg Rev       Date:  2020-02-06       Impact factor: 3.042

Review 7.  Unyielding progress: recent advances in the treatment of central nervous system neoplasms with radiosurgery and radiation therapy.

Authors:  Dale Ding; Chun-Po Yen; Robert M Starke; Cheng-Chia Lee; Jason P Sheehan
Journal:  J Neurooncol       Date:  2014-08-14       Impact factor: 4.130

8.  Significant temporal evolution of diffusion anisotropy for evaluating early response to radiosurgery in patients with vestibular schwannoma: findings from functional diffusion maps.

Authors:  Y-C Lin; C-C Wang; Y Y Wai; Y-L Wan; S-H Ng; Y-L Chen; H-L Liu; J-J Wang
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-24       Impact factor: 3.825

9.  American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS).

Authors:  Steven K Seung; David A Larson; James M Galvin; Minesh P Mehta; Louis Potters; Christopher J Schultz; Santosh V Yajnik; Alan C Hartford; Seth A Rosenthal
Journal:  Am J Clin Oncol       Date:  2013-06       Impact factor: 2.339

10.  Quality of life after gamma knife radiosurgery treatment in patients with a vestibular schwannoma: the patient's perspective.

Authors:  Ferdinand C A Timmer; Anniek E P van Haren; Jef J S Mulder; Patrick E J Hanssens; Jacobus J van Overbeeke; Cor W R J Cremers; Kees Graamans
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-06       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.